Improving Treatment Outcomes through Danny Analytics

Sofia, May 15, 2018 – Sqilline officially launched its newest application Danny Analytics for analyzing and evaluating massive amounts of real-world data from oncology and cardiology fields. Danny Analytics enables physicians, pharmaceutical companies and payers to gain insight into real-world evidence of patient care, particularly in this era of value-based care.

Powered by SAP HANA DB, our solution taps into the capabilities of rapid in-memory data processing and computation for improving healthcare Danny Analytics provides real-time aggregated analyses of structured and unstructured health data with integration of registries, external clinical and drug databases, etc. It utilizes proprietary algorithms and methodologies for data quality, data validation and predictive insights based on de-identified patient records.

By harnessing the power of modern technology, the solution is an advanced tool for: 

  • Quick and understandable visualization of clinical data from health records, hospital information systems, and other registries
  • Analyses on how specific factors influence patient survival and comparison of the effectiveness of different treatment options
  • Accumulation of large systemized analytical datasets – Big Data
  • Large cohorts of patients are compared and analyzed within seconds
  • Data security and patient privacy

For pharmaceutical companies, Danny Analytics can provide real-world evidence to update drug labels, drug effectiveness, market access and adjust drug production in oncology and cardiology.

For government health institutions (payers), Danny Analytics can support the process of transforming healthcare based on therapeutic approach, effectiveness, and safety, which in turn deliver high-quality, cost-effective care to all.

Danny Analytics is already uploaded with data from several leading Oncology hospitals in Bulgaria and has accumulated powerful data reports in specific diseases for physicians and researchers.

Sqilline is a leading SAP Partner in Europe in the areas of Precision Medicine, Life Science and Healthcare. Our team has built the 1st Analytics Healthcare platform for real-world data for the two of the largest health areas – Oncology and Cardiology in Central and Eastern Europe.

Presenting on stage is Sqilline’s Managing Director – Ms. Desislava Mihaylova
Presenting on stage is Sqilline’s Senior Data Scientist – Mr. Boyang Zhao, PhD
Special guests at the launch (from left to right) – Dr. Borislav Borisov, Prof. Dr. Galina Kurteva and Prof. Dr. Ivo Petrov
Share this article:

More News & Highlights


AI-enabled prediction of clinical outcomes, based on RWD from EHRs

What is Artificial intelligence (AI) in healthcare? It refers to the ability of a machine to perform tasks commonly associated with intelligent human behavior without...



Sqilline assures quality of data with add-on features

The platform, powered by SAP HANA, has already generated powerful data reports and insights in specific diseases for physicians and researchers Danny Platform is an Analytics...



How to measure value in cancer immunotherapy

One of the most fundamental questions facing any health care system is whether the resources invested are achieving the maximum result. Another way of phrasing...